[{"Assets_0_FY_USD":424464000.0,"CommonStockSharesOutstanding_0_FY_shares":51314850.0,"EarningsPerShareBasic_1_FY_USD":0.27,"EarningsPerShareBasic_4_FY_USD":1.13,"EarningsPerShareDiluted_1_FY_USD":0.26,"EarningsPerShareDiluted_4_FY_USD":1.08,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":114640000.0,"NetIncomeLoss_1_FY_USD":13658000.0,"NetIncomeLoss_4_FY_USD":57284000.0,"StockholdersEquity_0_FY_USD":267480000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":53301150.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":50756603.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS INC","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180301"}]